mBio (Oct 2023)

Targeted curation of the gut microbial gene content modulating human cardiovascular disease

  • Mikayla A. Borton,
  • Michael Shaffer,
  • David W. Hoyt,
  • Ruisheng Jiang,
  • Jared B. Ellenbogen,
  • Samuel Purvine,
  • Carrie D. Nicora,
  • Elizabeth K. Eder,
  • Allison R. Wong,
  • A. George Smulian,
  • Mary S. Lipton,
  • Joseph A. Krzycki,
  • Kelly C. Wrighton

DOI
https://doi.org/10.1128/mbio.01511-23
Journal volume & issue
Vol. 14, no. 5

Abstract

Read online

ABSTRACT Despite the promise of the gut microbiome to predict human health, few studies expose the molecular-scale processes underpinning such forecasts. We mined over 200,000 gut-derived genomes from cultivated and uncultivated microbial lineages to inventory the gut microorganisms and their gene content that control trimethylamine-induced cardiovascular disease. We assigned an atherosclerotic profile to the 6,341 microbial genomes that encoded metabolisms associated with heart disease, creating the Methylated Amine Gene Inventory of Catabolism database (MAGICdb). From microbiome gene expression data sets, we demonstrate that MAGICdb enhanced the recovery of disease-relevant genes and identified the most active microorganisms, unveiling future therapeutic targets. From the feces of healthy and diseased subjects, we show that MAGICdb predicted cardiovascular disease status as effectively as traditional lipid blood tests. This functional microbiome catalog is a public, exploitable resource, designed to enable a new era of microbiota-based therapeutics and diagnostics. IMPORTANCE One of the most-cited examples of the gut microbiome modulating human disease is the microbial metabolism of quaternary amines from protein-rich foods. By-products of this microbial processing promote atherosclerotic heart disease, a leading cause of human mortality globally. Our research addresses current knowledge gaps in our understanding of this microbial metabolism by holistically inventorying the microorganisms and expressed genes catalyzing critical atherosclerosis-promoting and -ameliorating reactions in the human gut. This led to the creation of an open-access resource, the Methylated Amine Gene Inventory of Catabolism database, the first systematic inventory of gut methylated amine metabolism. More importantly, using this resource we deliver here, we show for the first time that these gut microbial genes can predict human disease, paving the way for microbiota-inspired diagnostics and interventions.

Keywords